COPD Morbidity, Mortality and Unrecognized, Untreated Thromboembolism
Can early initiation of anticoagulation therapy in inpatients with COPD exacerbations reduce increasing morbidity and mortality among these patients?
Can early initiation of anticoagulation therapy in inpatients with COPD exacerbations reduce increasing morbidity and mortality among these patients?
Researchers assessed whether integrating multiorgan focused clinical ultrasonography with the clinical evaluation of patients with a cardiopulmonary diagnosis would decrease hospital stay and costs.
A model integrating clinical data with electrocardiogram (ECG) waveforms may improve prediction of pulmonary embolism (PE).
How effective are the antifibrotic agents nintedanib and pirfenidone for patients with idiopathic pulmonary fibrosis and non-IPF?
Could calcium levels serve as a possible prognostic marker for in-hospital mortality among patients with pulmonary embolism?
What is the optimal D-dimer cutoff value for predicting post-cesarean section pulmonary embolism?
Diagnostic strategies for suspected PE with pretest probability-dependent D-dimer thresholds have the highest efficiency and highest predicted failure rate.
French investigators created a novel scoring system, the PE-SARD, to estimate the risk of early major bleeding in patients with acute pulmonary embolism.
The rate of recurrent venous thromboembolism is higher than expected for patients with subsegmental pulmonary embolism managed without anticoagulation.
Researchers analyzed the temporal trend in racial and ethnic differences in the use of intravenous thrombolysis after stroke between 2009 and 2018 in a representative sample of adults in the US.